Network medicine framework for identifying drug-repurposing opportunities for COVID-19

D Morselli Gysi, Í Do Valle, M Zitnik… - Proceedings of the …, 2021 - National Acad Sciences
The COVID-19 pandemic has highlighted the need to quickly and reliably prioritize clinically
approved compounds for their potential effectiveness for severe acute respiratory syndrome …

Deep learning of pharmacogenomics resources: moving towards precision oncology

YC Chiu, HIH Chen, A Gorthi, M Mostavi… - Briefings in …, 2020 - academic.oup.com
The recent accumulation of cancer genomic data provides an opportunity to understand how
a tumor's genomic characteristics can affect its responses to drugs. This field, called …

Cas9 activates the p53 pathway and selects for p53-inactivating mutations

OM Enache, V Rendo, M Abdusamad, D Lam… - Nature …, 2020 - nature.com
Cas9 is commonly introduced into cell lines to enable CRISPR–Cas9-mediated genome
editing. Here, we studied the genetic and transcriptional consequences of Cas9 expression …

Morphology and gene expression profiling provide complementary information for mapping cell state

GP Way, T Natoli, A Adeboye, L Litichevskiy, A Yang… - Cell systems, 2022 - cell.com
Morphological and gene expression profiling can cost-effectively capture thousands of
features in thousands of samples across perturbations by disease, mutation, or drug …

Noncanonical open reading frames encode functional proteins essential for cancer cell survival

JR Prensner, OM Enache, V Luria, K Krug… - Nature …, 2021 - nature.com
Although genomic analyses predict many noncanonical open reading frames (ORFs) in the
human genome, it is unclear whether they encode biologically active proteins. Here we …

Integrated molecular characterisation of the MAPK pathways in human cancers reveals pharmacologically vulnerable mutations and gene dependencies

M Sinkala, P Nkhoma, N Mulder, DP Martin - Communications Biology, 2021 - nature.com
The mitogen-activated protein kinase (MAPK) pathways are crucial regulators of the cellular
processes that fuel the malignant transformation of normal cells. The molecular aberrations …

Pharmacogenomics and big genomic data: from lab to clinic and back again

A Lavertu, G McInnes, R Daneshjou… - Human molecular …, 2018 - academic.oup.com
The field of pharmacogenomics is an area of great potential for near-term human health
impacts from the big genomic data revolution. Pharmacogenomics research momentum is …

A cryogenic, coincident fluorescence, electron, and ion beam microscope

DB Boltje, JP Hoogenboom, AJ Jakobi, GJ Jensen… - Elife, 2022 - elifesciences.org
Cryogenic electron tomography (cryo-ET) combined with subtomogram averaging, allows in
situ visualization and structure determination of macromolecular complexes at …

Drug target inference by mining transcriptional data using a novel graph convolutional network framework

F Zhong, X Wu, R Yang, X Li, D Wang, Z Fu, X Liu… - Protein & …, 2022 - academic.oup.com
ABSTRACT A fundamental challenge that arises in biomedicine is the need to characterize
compounds in a relevant cellular context in order to reveal potential on-target or off-target …

Side effect prediction based on drug-induced gene expression profiles and random forest with iterative feature selection

A Cakir, M Tuncer, H Taymaz-Nikerel… - The Pharmacogenomics …, 2021 - nature.com
One in every ten drug candidates fail in clinical trials mainly due to efficacy and safety
related issues, despite in-depth preclinical testing. Even some of the approved drugs such …